Skip to main content
KONICA MINOLTA, INC. logo

KONICA MINOLTA, INC. — Investor Relations & Filings

Ticker · 4902 ISIN · JP3300600008 LEI · 549300SVK6KRUOL1A740 T Manufacturing
Open in API
Filings indexed 81 across all filing types
Latest filing 2025-02-13 Capital/Financing Update
Country JP Japan
Listing T 4902

About KONICA MINOLTA, INC.

https://www.konicaminolta.com/africa3-e…

Konica Minolta, Inc. is a technology company specializing in imaging-based products, services, and solutions. The company's operations are structured across several key business areas. The Digital Workplace division provides multi-functional peripherals (MFPs), printers, and associated IT services for office environments. The Professional Print business offers production printing systems, including the AccurioPress series for graphic arts and commercial printing, as well as inkjet systems for the textile industry. In the healthcare sector, Konica Minolta develops and manufactures medical diagnostic imaging solutions such as X-ray and ultrasound systems. The company also produces high-precision measuring instruments for light and color, advanced materials and components for industrial use, and provides comprehensive planetarium solutions, from projectors and domes to content production.

Recent filings

Filing Released Lang Actions
訂正発行登録書
Capital/Financing Update Classification · 95% confidence The document is explicitly titled "訂正発行登録書" (Correction Registration Statement) and is filed with the Kanto Local Finance Bureau (関東財務局長). It concerns the registration of corporate bonds ("社債") and references a previous registration statement from 2023. The core purpose is related to the registration and issuance of securities, specifically debt financing. This aligns best with the 'Capital/Financing Update' category (CAP), as it deals directly with the registration of bonds intended for issuance, even though it is a correction filing. It is not a general earnings release (ER), a full annual report (10-K), or a simple dividend notice (DIV). Since it is a formal regulatory filing related to capital structure/financing, CAP is the most appropriate specific code.
2025-02-13 Japanese
臨時報告書
Management Reports Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau Director on February 13, 2025. The filing reason explicitly states that the report is submitted because an event significantly impacting the consolidated financial condition, operating results, and cash flow has occurred, citing Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act. The content details significant impairment losses (減損損失) recognized in the third quarter due to customer investment suppression and a change in plans regarding the sale of a subsidiary (Konica Minolta Opto (Dalian) Co., Ltd). This structure—a formal, unscheduled report detailing a material event that affects financial results—is characteristic of a Japanese Extraordinary Disclosure filing, which corresponds best to the general 'Regulatory Filings' category (RNS) or potentially a specific type of material event disclosure not explicitly listed. Given the options, 'RNS' (Regulatory Filings) is the most appropriate fallback for a formal, unscheduled disclosure of material financial impact that isn't a standard periodic report (10-K, IR) or an earnings release (ER). The document length is short (1641 chars), suggesting it is the announcement/filing itself, not the full underlying report.
2025-02-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the title "第２四半期報告書" (Second Quarter Report) and explicitly mentions the period covered: "自 2024年４月１日 至 2024年９月30日" (From April 1, 2024, to September 30, 2024). It also includes confirmation statements by the CEO and CFO regarding the appropriateness of the filing content based on financial instruments laws, referencing the '半期報告書' (Half-Year Report). This structure and content strongly indicate a comprehensive financial report for an interim period shorter than a year. This aligns perfectly with the definition of an Interim / Quarterly Report (Code: IR). The document length is short (601 chars), but it appears to be the core content/confirmation section of the report itself, not just an announcement of its publication, making IR more appropriate than RPA or RNS.
2024-11-12 Japanese
半期報告書－第121期(2024/04/01－2025/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) for Konica Minolta, Inc. for the period ending September 30, 2024. It contains detailed financial statements, management analysis (MDA), and segment reporting, which aligns with the definition of an Interim/Quarterly Report (IR). It is not a mere announcement or certification, as it provides substantive financial data and analysis. H1 2025
2024-11-12 Japanese
訂正発行登録書
Capital/Financing Update Classification · 95% confidence The document is titled "訂正発行登録書" (Correction Registration Statement) and is filed with the Kanto Local Finance Bureau ("関東財務局長"). It specifically references a previous "発行登録書" (Registration Statement) for "社債" (Corporate Bonds) and details the reason for the correction relates to the submission of a "臨時報告書" (Extraordinary Report). This document concerns the registration of securities issuance (capital raising/financing) and is a formal regulatory filing related to debt instruments. While it is a correction to a registration statement, the core activity described falls under financing activities. Given the options, 'Capital/Financing Update' (CAP) is the most appropriate category for filings related to the registration and issuance of corporate bonds, even if this specific document is a correction filing. It is not a general regulatory announcement (RNS) because it pertains to a specific financing event.
2024-11-05 Japanese
臨時報告書
Regulatory Filings Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau Director on November 5, 2024. The filing reason explicitly states that an event significantly impacting the consolidated financial condition, operating results, and cash flow has occurred, citing Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act. The content details the decision to sell all shares of a consolidated subsidiary (Ambry Genetics Corporation) and estimates the resulting profit impact on the consolidated financial statements for the fiscal year ending March 2025. This structure—a formal, unscheduled report detailing a significant, non-routine corporate event (like a major divestiture) that affects financial results—is characteristic of a Japanese Extraordinary Disclosure filing, which often corresponds to the US SEC's 8-K filing. Among the provided codes, 'RNS' (Regulatory Filings) is the most appropriate general category for miscellaneous, non-periodic regulatory disclosures that don't fit the specific financial report types (10-K, IR, ER) or specific event types (DIV, CAP, TAR). Given the context of a formal, mandatory disclosure of a significant event, RNS is the best fit as a catch-all for specific regulatory filings not otherwise categorized.
2024-11-05 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.